{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-034579","form_type":"8-K","ticker":"APGE","cik":"0001974640","company_name":"Apogee Therapeutics, Inc.","filed_at":"2026-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.913163+00:00","generated_at":"2026-05-15T09:05:40.348983+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Apogee Therapeutics prices public offering of 5M shares at $70, net ~$377.4M","bullets":["5,000,000 shares offered at $70 per share; underwriters' option for 750,000 shares exercised in full.","Net proceeds expected ~$377.4M after underwriting discounts and commissions and estimated expenses.","Offering expected to close March 26, 2026; underwriters include Jefferies, TD Securities, Stifel, Guggenheim.","Shares sold under shelf registration statement (File No. 333-281503) effective August 12, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-034579","json":"https://secwatch.observer/filing/0001104659-26-034579.json","markdown":"https://secwatch.observer/filing/0001104659-26-034579.md","text":"https://secwatch.observer/filing/0001104659-26-034579.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/0001104659-26-034579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/tm269761d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:05:40.348983+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7a8c5d897ffc53a2d4e5777657601a62f126daa9","claim":"Apogee Therapeutics, Inc. entered into Underwriting Agreement with Jefferies LLC, TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC valued at $70.00 per share (effective 2026-03-24).","evidence_excerpt":"On March 24, 2026, Apogee Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (“Underwriting Agreement”) with Jefferies LLC, TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC, as the representatives of the Underwriters named therein (the “Underwriters”), to issue and sell 5,000,000 shares of the Company’s common stock at a public offering price of $70.00 per share (the “Offering”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/0001104659-26-034579-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Jefferies LLC, TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC"},{"label":"Value","value":"$70.00 per share"},{"label":"Effective","value":"2026-03-24"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}